New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 2 years ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
- Geospatial immune heterogeneity reflects the diverse tumor-immune interactions i
- 1
- 1
- 2 years, 4 months ago
- Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2
- 1
- 1
- 2 years, 4 months ago
- Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pa
- 1
- 1
- 2 years, 4 months ago
- Geospatial immune heterogeneity reflects the diverse tumor-immune interactions i
- 1
- 1
- 2 years, 4 months ago
- The Co-mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 F
- 1
- 1
- 2 years, 4 months ago
- A gene signature is critical for intrahepatic cholangiocarcinoma stem cell self-
- 1
- 1
- 2 years, 4 months ago
- KRAS mutation in intrahepatic cholangiocarcinoma: linkage with metastasis-free s
- 1
- 1
- 2 years, 4 months ago
- Anatomic patterns of recurrence in biliary tract cancers: does primary tumor sit
- 1
- 1
- 2 years, 4 months ago
- The path to personalized treatment in advanced and metastatic biliary tract canc
- 1
- 1
- 2 years, 4 months ago
- Patient reported outcomes: Financial toxicity is a barrier to clinical trials an
- 1
- 1
- 2 years, 4 months ago
- The forum ‘New Developments’ is closed to new topics and replies.